BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Clinical Outcome
10 results:

  • 1. stat3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.
    Huo N; Cong R; Sun ZJ; Li WC; Zhu X; Xue CY; Chen Z; Ma LY; Chu Z; Han YC; Kang XF; Jia SH; Du N; Kang L; Xu XJ
    Cell Death Dis; 2021 Aug; 12(9):799. PubMed ID: 34404767
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via stat3 dephosphorylation in nasopharyngeal carcinoma.
    Lin Y; Zhou X; Yang K; Chen Y; Wang L; Luo W; Li Y; Liao J; Zhou Y; Lei Y; Zhang Y; Wu D; Cai L
    Oncogene; 2021 Apr; 40(17):3101-3117. PubMed ID: 33824475
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. AF1q Expression Associates with CD44 and stat3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the head and neck.
    Kadletz LC; Brkic FF; Jank BJ; Schneider S; Cede J; Seemann R; Gruber ES; Gurnhofer E; Heiduschka G; Kenner L
    Pathol Oncol Res; 2020 Apr; 26(2):1287-1292. PubMed ID: 31273546
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis.
    Dong H; Xu J; Li W; Gan J; Lin W; Ke J; Jiang J; Du L; Chen Y; Zhong X; Zhang D; Yeung SJ; Li X; Zhang H
    J Pathol; 2017 Mar; 241(4):448-462. PubMed ID: 27801498
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.
    Psyrri A; Lee JW; Pectasides E; Vassilakopoulou M; Kosmidis EK; Burtness BA; Rimm DL; Wanebo HJ; Forastiere AA
    Clin Cancer Res; 2014 Jun; 20(11):3023-32. PubMed ID: 24700741
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma.
    Chen MF; Lu MS; Lin PY; Chen PT; Chen WC; Lee KD
    Cancer; 2012 Aug; 118(16):4074-89. PubMed ID: 22213175
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
    Chen CC; Chen WC; Lu CH; Wang WH; Lin PY; Lee KD; Chen MF
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1214-24. PubMed ID: 20206020
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis.
    Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ
    Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
    Agulnik M; da Cunha Santos G; Hedley D; Nicklee T; Dos Reis PP; Ho J; Pond GR; Chen H; Chen S; Shyr Y; Winquist E; Soulieres D; Chen EX; Squire JA; Marrano P; Kamel-Reid S; Dancey J; Siu LL; Tsao MS
    J Clin Oncol; 2007 Jun; 25(16):2184-90. PubMed ID: 17538163
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.